Experimental drug eliminates 75% of aggressive pancreatic tumors and enhances immune system memory
MedPacto reported that its experimental drug MP010 eliminated 75% to 87.5% of aggressive pancreatic tumors in mice.
20 trends tracked about this subject — the full history, oldest to newest below.
MedPacto reported that its experimental drug MP010 eliminated 75% to 87.5% of aggressive pancreatic tumors in mice.
Research suggests seasonal influenza vaccines may activate immune responses against skin cancer tumors in early studies.
Marengo Therapeutics' Invikafusp alfa shows promise in treating TMB-H solid tumors resistant to standard immune checkpoint blockade.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Cancer vaccines emerge as a major focus for the N.I.H. through a newly announced public-private partnership.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines a blood-based approach capable of identifying cancer targets and reactive T cells without biopsies.
Recent scientific studies reveal how high-fat diets and tumor metabolism can help colorectal cancer spread to the liver.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
14 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
13 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research reveals that tumors may weaponize antioxidant proteins to disable the reactive oxygen species T cells need to destroy cancer.
Inhibrx claims a first-of-its-kind win for a long-sought immunotherapy target with new clinical data.
New research suggests that administering cancer immunotherapy in the morning may significantly improve patient survival outcomes.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent reports suggest the common workout supplement creatine may enhance the effectiveness of cancer immunotherapy.
New GPNMB‑CAR‑T therapy shows promise against the deadliest brain cancer, glioblastoma.
A high-profile study on the timing of lung cancer immunotherapy has been retracted by Nature Medicine following a four-month investigation.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A lupus treatment borrowed from cancer therapy is putting patients into remission—with one calling it life-changing.